|
全民健康保險藥品給付規定 / 健保碼及健保價 |
|
See related Zoladex LA inj[諾雷德 持續性注射劑] information |
|
|
|
製造商 |
AstraZeneca |
|
代理/經銷商 |
AstraZeneca |
|
成份 |
Goserelin |
|
適應症 |
Prostate cancer. |
|
用量 |
Adult 10.8 mg SC 12 weekly. |
|
過量 |
View Zoladex LA[諾雷德] overdosage for action to be taken in the event of an overdose. |
|
美國食品藥物管理局之懷孕等級 |
Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there is evidence of foetal risk based on human experience or both, and the risk of the use of the drug in pregnant women clearly outweighs any possible benefit. The drug is contraindicated in women who are or may become pregnant. |
|
禁忌 |
Women, child. |
|
注意事項 |
Men at risk of developing ureteric obstruction or spinal cord compression. Women with known metabolic bone disease. |
|
不良反應 |
Arthralgia, BP change. Hot flushes, decrease in libido. Infrequently breast swelling & tenderness. Increase in bone pain. Spine cord compression.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
|
副作用 |
View Zoladex LA[諾雷德] side effects |
|
交互作用 |
[Click for Zoladex LA[諾雷德] detailed prescribing infomation]
View more drug interactions with Zoladex LA[諾雷德] |
|
儲存 |
View Zoladex LA[諾雷德] storage conditions for details to ensure optimal shelf-life. |
|
描述 |
View Zoladex LA[諾雷德] description for details of the chemical structure and excipients (inactive components). |
|
作用 |
View Zoladex LA[諾雷德] mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
本商品之市售規格 |
|
|
|
Manufacturer: |
AstraZeneca |
|
Distributor: |
AstraZeneca |
|
|
|
|
